资讯

Fierce Pharma27 分钟
Merck's Keytruda finds a path in ovarian cancer with phase 3 win in certain patients
Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. | ...